TYK230: Difference between revisions
Bot: Automated import of articles |
m Text replacement - "<p style="text-align: center;"> About Test Your Knowledge</p>" to "<p style="text-align: center;"> About Test Your Knowledge</p> Category:TYK" |
||
| (One intermediate revision by the same user not shown) | |||
| Line 32: | Line 32: | ||
<p style="text-align: center;">[[TYK229|<Prev Question]] --- [[TYK231|Next Question>]]</p> | <p style="text-align: center;">[[TYK229|<Prev Question]] --- [[TYK231|Next Question>]]</p> | ||
<p style="text-align: center;">[[TYK About | About Test Your Knowledge]]</p> | <p style="text-align: center;">[[TYK About | About Test Your Knowledge]]</p> | ||
[[Category:TYK]] | |||
Latest revision as of 02:17, 25 September 2026
Assuming a constant infusion of intravenous heparin at steady-state, administration of which of the following will SHORTEN the partial thromboplastin time (PTT):
a) FFP
b) Antithrombin III
c) Vitamin K
d) A and B
e) None of the above
Click for Answer
Answer
Answer e. Vitamin K administration does not generally affect the intrinsic coagulation pathway, and thus does not change the PTT. In contrast, fresh frozen plasma and antithrombin III administration provide additional substrate for heparin anticoagulation (which functions via potentiation of antithrombin), and result in a paradoxical prolongation of the PTT.
Notes
- This question originally printed in the Pediatric Anesthesiology Review Topics kindle book series, and appears courtesy of Naerthwyn Press, LLC.